Physician profile
Mark Block
NPI 1225034176
$1,745.43
in general payments reported to CMS, 2019-2025
13 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $103 · 2021: $207 · 2022: $367 · 2023: $148 · 2024: $274 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $323.80 | 2019-2021 | |
| Smith+Nephew, INC. | $254.83 | 2019-2024 | Collagenase Santyl, Oasis, Versajet |
| Paratek Pharmaceuticals, INC. | $246.91 | 2023-2024 | Nuzyra |
| Amgen INC. | $149.50 | 2025 | Krystexxa |
| Shockwave Medical, INC | $140.40 | 2022 | |
| Depuy Synthes Sales INC. | $136.33 | 2022 | |
| Boston Scientific Corporation | $122.73 | 2019 | |
| Integra Lifesciences Corporation | $109.76 | 2019 | |
| Djo, LLC | $102.72 | 2020 | |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Kci USA, INC. | $26.47 | 2023 | Snap |
| Organogenesis INC. | $22.36 | 2019 | |
| Cashflow Solutions, LLC | $19.79 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.